Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications

Malignant pleural mesothelioma (MPM) tumors are remarkably aggressive and most patients only survive for 5–12 months; irrespective of stage; after primary symptoms appear. Compounding matters is that MPM remains unresponsive to conventional standards of care; including radiation and chemotherapy. Cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolani, Bhairavi, Acevedo, Luis A., Hoang, Ngoc T., He, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796186/
https://www.ncbi.nlm.nih.gov/pubmed/29342862
http://dx.doi.org/10.3390/ijms19010238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796186/
https://www.ncbi.nlm.nih.gov/pubmed/29342862
http://dx.doi.org/10.3390/ijms19010238

Ejemplares similares